Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2007 / Cilt: 4 - Sayı: 4

Pregnancy outcome with intrahepatic cholestasis

İntrahepatik kolestazda gebelik sonuçları

Pages
250–253
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a need for antenatal fetal and maternal monitoring.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate the management and outcome of obstetric cholestasis in our perinatology unit.
📊
Key Findings & Data:MATERIALS-METHODS: We analyzed forty pregnant patients complicated by cholestasis who gave birth at our hospital from January 2003 to December 2006.RESULTS: Forty women of mean age 29.72±6.42 years delivered 51 newborns.
💡
Conclusion & Impact:There is a need for antenatal fetal and maternal monitoring.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To evaluate the management and outcome of obstetric cholestasis in our perinatology unit. MATERIALS-METHODS: We analyzed forty pregnant patients complicated by cholestasis who gave birth at our hospital from January 2003 to December 2006.RESULTS: Forty women of mean age 29.72±6.42 years delivered 51 newborns. The median gestation at diagnosis of obstetric cholestasis was 32.35±3.78 weeks. Twenty-four women required caesarean section (%60); only eight (%33.3) were for fetal distress. Ten women (%25) delivered before 37 weeks. Incidence of meconium stained liquor in labour was % 17.6. 11.7% of babies were admitted to the neonatal unit mainly due to prematurity. Perinatal mortality rate was found % 3.9. CONCLUSIONS: Clinical features and laboratory investigations are essential for the diagnosis of obstetric cholestasis. There is a need for antenatal fetal and maternal monitoring.

Özet

AMAÇ: Perinatoloji servisimizde, obstetrik kolestaz tanısı konulan hastaların yönetimini ve gebelik sonuçlarını değerlendirmek. MATERYAL-METOD: Ocak 2002 ile Aralık 2006 yılları arasında, hastanemizde doğum yapan obstetrik kolestaz tanılı kırk hasta analiz edildi. BULGULAR: Ortalama yaşları 29.72±6.42 olan kırk hasta, 51 bebek doğurdu. Obstetrik kolestazın ortalama tanı haftası 32.35±3.78 hafta olarak bulundu. Gebelerin %60’ı sezaryen ile doğum yaptı. Bu oranın sadece sekizi (% 33.3) fetal distres endikasyonu ile idi. On hasta (%25) otuz yedinci gebelik haftasından önce doğum yaptı. Ammiyotik sıvıda mekonyum % 17.6 oranında tespit edildi. Yeni doğan unitesine kabul oranı %11.7 oranında bulundu. Perinatal mortalite oranı %3.9 idi. SONUÇ: Obstetrik kolestaz tanısı, klinik bulgulara ve laboratuar incelemeleri sonucunda konur. Antenatal dönemde, fetal ve maternal izlem gerekmektedir.

🔖

Cite This Article

YILDIRIM, G., GÜNGÖRDÜK, K., GEDİKBAŞI, A., ASLAN, H., CEYLAN, Y., ASAR, E., ŞAFAK, I. (2022). Pregnancy outcome with intrahepatic cholestasis. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 4 - Sayı: 4, 250–253. https://ajindex.com/articles/631750

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Schorr-Lesnick B, Lebovics E, Dworkin B, Rosenthal WS. Liver diseases unique to pregnancy. Am J Gastroenterol 1991; 86:659- 70
  2. Svenborg A. A study of recurrent Jaundice in pregnancy. Acta Obstet Gynecol Scand. 1954; 33: 434- 44
  3. Reyes H, Simon F. Intrahepatic cholestasis of pregnancy: An estrogen-related disease. Semin Liver Dis 1993; 33: 434- 44
  4. Holzbach RT, Sivak DA, Braun WE. Familial recurrent intrahepatic cholestasis of pregnancy. A genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology 1983; 85: 175- 9
  5. Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, et al. A randomised controlled trail of ursodeoxycholic acid and S-adenosyl-1-methionine in the treatment of gestational cholestasis. BJOG 2004; 111: 17- 21
  6. Hirvioja ML, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. BJOG 1992; 99: 109- 111
  7. Davres MH, da Silva RC, Jones SR, Weaver JB, Elias E. fetal mortality associated with cholestasis of pregnancy and the potential benefit of theraphy with ursodeoxycholic acid. Gut 1995; 37: 580- 4
  8. Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996; 175:957- 60
  9. Davidson KM. Intrahepatic cholestasis of preganancy. Seminars in Perinatology 1998; 22: 104- 11
  10. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastro Clin North Am 1992; 21: 905- 21
  11. Shaw D, Frohlik J, Wittmann BAK, Willms MI. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 1982; 142: 621- 5
  12. Arrese M, Reyes H. Intrahepatic cholestasis of pregnacy: A past and present riddle. Annals of Hepatology 2006; 5: 202- 5
  13. Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetrics cholestasis. BMJ 1976; 1: 870- 2
  14. Monte MJ, Morales AI, Arevalo M, et al. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis. Hepatology 1996; 23. 1208- 17
  15. Costaya A, Leontic E, Rosenberg H, et al. Morphological study of placental terminal villi in intrahepatic cholestasis of pregnancy: Histochemical, light, and electron microscopy. Placenta 1980;1: 361- 8
  16. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome.